11.01.02
Innovative Technology Acquisition Corp., BST Enter into Agreement
Toronto, Canada-based Innovative Technology Acquisition Corporation has entered into an agreement to acquire 100% of BioSource Therapeutics, Inc. (BST). BST is currently developing a dietary supplement that addresses the needs of people with catabolic caexiea, commonly referred to as “wasting syndrome” in diseases such as HIV/AIDS, hepatitis and cancer.